|Home||» Products||» Pharmaceutical Drugs||» Ambrisentan|
Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name pulmonext by MSN labs ) is a drug indicated for use in the treatment of pulmonary hypertension
Ambrisentan was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency, and designated anorphan drug, for the treatment of pulmonary hypertension.
DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.